The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
The really sad thing is how many of the parents would have allowed their children to go through this awful procedure if they had known about AVA 6000.
The safety of AVA 6000 has been all but proven, it's so frustrating that so few people have ever heard of it.
Alastair Smith
"It's critical for us to maintain our lead chemical program, so we would not be aiming to partner AVA6000.
Of course, unless there was an extremely compelling opportunity."
I'm thinking there's going to be an extremely compelling opportunity coming down the tracks fairly soon.
Good luck all.
Totally agree Energy, if it's working not only the FDA but all cancer patients will want this available as a treatment ASAP.
Who on earth would want standard doxorubicin pumped into them with AVA6000 around.
The logistics of bringing AVA6000 to market quickly is way beyond Avacta’s capability, I can only hope that they already in talks with big pharma.
GLA